U Walter Selected Research

U Walter Research Topics

Disease

3	Cardiovascular Diseases (Cardiovascular Disease) 11/2015 - 11/2000
3	Parkinson Disease (Parkinson's Disease) 04/2008 - 04/2004
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2018 - 01/2013
2	Hemorrhage 08/2009 - 11/2006
2	Thromboembolism 11/2006 - 10/2002
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2003 - 04/2000
2	Inflammation (Inflammations) 11/2000 - 02/2000
1	Stupor 01/2018
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016
1	Thrombosis (Thrombus) 01/2016
1	Pulmonary Hypertension 11/2015
1	Brain Death (Brain Dead) 04/2015
1	Lacunar Stroke 01/2013
1	Epilepsia Partialis Continua 01/2013
1	Ovarian Neoplasms (Ovarian Cancer) 12/2012
1	Stroke (Strokes) 01/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2009
1	Bipolar Disorder (Manic Depressive Psychosis) 03/2006
1	Schizophrenia (Dementia Praecox) 03/2006
1	Hepatolenticular Degeneration (Wilson's Disease) 05/2005
1	Basal Ganglia Diseases (Basal Ganglia Disease) 11/2004
1	Hemophilia A (Haemophilia) 11/2001
1	Diabetes Mellitus 02/2001
1	Vesicular Stomatitis 08/2000
1	Human Influenza (Influenza) 04/2000
1	Experimental Arthritis 02/2000

Drug/Important Bio-Agent (IBA)

3	IronIBA 09/2009 - 04/2004
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 08/2003 - 11/2000
2	Prothrombin (Factor II)IBA 10/2002 - 11/2001
2	Insulin (Novolin)FDA Link 02/2001 - 04/2000
1	Anesthetics (Anesthetic Agents)IBA 01/2018
1	Antiphospholipid AntibodiesIBA 01/2016
1	AntibodiesIBA 01/2016
1	Thromboplastin (Tissue Factor)IBA 01/2016
1	riociguatIBA 11/2015
1	Soluble Guanylyl CyclaseIBA 11/2015
1	Naloxone (Narcan)FDA LinkGeneric 04/2015
1	Sufentanil (Sufenta)FDA LinkGeneric 04/2015
1	Propofol (Diprivan)FDA LinkGeneric 04/2015
1	NormetanephrineIBA 01/2013
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2013
1	Cisplatin (Platino)FDA LinkGeneric 12/2012
1	PlatinumIBA 12/2012
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2011
1	Leucine (L-Leucine)FDA Link 04/2008
1	Phosphotransferases (Kinase)IBA 04/2008
1	cancer procoagulantIBA 11/2006
1	Blood Coagulation Factors (Coagulation Factor)IBA 11/2006
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2006
1	EnzymesIBA 03/2006
1	CopperIBA 05/2005
1	Ceruloplasmin (Ferroxidase)IBA 11/2004
1	Messenger RNA (mRNA)IBA 08/2003
1	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 10/2002
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2002
1	factor V LeidenIBA 10/2002
1	Endothelial Protein C ReceptorIBA 10/2002
1	activated protein C receptorIBA 10/2002
1	recombinant FVIIa (rFVIIa)FDA Link 11/2001
1	GuanosineIBA 11/2000
1	Extracellular Matrix ProteinsIBA 11/2000
1	Protein Kinases (Protein Kinase)IBA 11/2000
1	LigandsIBA 11/2000
1	Adenosine (Adenocard)FDA LinkGeneric 11/2000
1	8-((4-chlorophenyl)thio)cyclic-3',5'-GMPIBA 08/2000
1	Cell Surface ReceptorsIBA 04/2000
1	Hemagglutinins (Hemagglutinin)IBA 04/2000
1	Peptides (Polypeptides)IBA 04/2000
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2000
1	Chemotactic FactorsIBA 02/2000
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 02/2000
1	P-SelectinIBA 02/2000
1	SelectinsIBA 02/2000
1	IntegrinsIBA 02/2000
1	ZymosanIBA 02/2000

Therapy/Procedure

3	Therapeutics 01/2013 - 08/2001
1	Critical Care (Surgical Intensive Care) 04/2015